An overview on NASH disease
and future treatments
Special Thanks to Albert Wright for his strong help in the translation.
If you liked this site, free of any advertizing, you can offer us a coffee.
Si ce site vous a été utile, comme il ne comporte aucune publicité, vous pouvez aider l’auteur à le maintenir en lui offrant un café.
le café diminue le risque de NASH
This publication reflects the views only of the authors, and he cannot be held responsible for any use which may be made of the information contained therein. The authors of the articles published here are not physician, financial analysts or market professionals. announced data may contain errors, inaccuracies and misinterpretations of facts.The authors could have their own stoks positions on these values. it is therefore recommended to the reader to verify the facts, to inform himself before any investment on listed companies and to make decisions based on his own judgment. the information and reflections that can be found on this website are by no means of incentives for the purchase or sale of listed securities but personal opinions of the authors, which does not represent the point of view of the mentionned companies
The main author is not english language native so you can find some gramatical errors or misspelling in the english translated articles. If you have time you can send corrections to author or better, you can propose a full article correction.
Positions of G.Divry on the biotech’s mentioned in articles:
GENFIT : H1 2013 - to date: Long
CONATUS : Oct 2016 - to date: No Position
GALT : Jan 2018 - to date: Long
IF YOU WANT TO JOIN A CLINICAL TRIAL ON NASH !
YOU ‘LL FIND BELOW A LIST OF RECRUITING TRIALS.
(click on it to have details, and more on binoculars)
If you are a laboratory with a ongoing clinical trial in NASH not mentionned here, please contact us at : contact @ nasbiotechs.com or use the form
